Literature DB >> 19793453

Simian varicella in old world monkeys.

Wayne L Gray1.   

Abstract

Simian varicella virus (SVV) causes a natural erythematous disease in Old World monkeys and is responsible for simian varicella epizootics that occur sporadically in facilities housing nonhuman primates. This review summarizes the biology of SVV and simian varicella as a veterinary disease of nonhuman primates. SVV is closely related to varicella-zoster virus, the causative agent of human varicella and herpes zoster. Clinical signs of simian varicella include fever, vesicular skin rash, and hepatitis. Simian varicella may range from a mild infection to a severe and life-threatening disease, and epizootics may have high morbidity and mortality rates. SVV establishes a lifelong latent infection in neural ganglia of animals in which the primary disease resolves, and the virus may reactivate later in life to cause a secondary disease corresponding to herpes zoster. Prompt diagnosis is important for control and prevention of epizootics. Antiviral treatment for simian varicella may be effective if administered early in the course of infection.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 19793453      PMCID: PMC2703154     

Source DB:  PubMed          Journal:  Comp Med        ISSN: 1532-0820            Impact factor:   0.982


  81 in total

Review 1.  Simian varicella virus infection in African and Asian monkeys. The potential for development of antivirals for animal diseases.

Authors:  K F Soike
Journal:  Ann N Y Acad Sci       Date:  1992-06-16       Impact factor: 5.691

2.  6-Dimethylamino-9-(beta-D-arabinofuranosyl)-9H-purine: pharmacokinetics and antiviral activity in simian varicella virus-infected monkeys.

Authors:  K F Soike; J L Huang; C U Lambe; D J Nelson; M N Ellis; T A Krenitsky; G W Koszalka
Journal:  Antiviral Res       Date:  1993-01       Impact factor: 5.970

3.  Acute simian varicella infection. Clinical, laboratory, pathologic, and virologic features.

Authors:  A N Dueland; J R Martin; M E Devlin; M Wellish; R Mahalingam; R Cohrs; K F Soike; D H Gilden
Journal:  Lab Invest       Date:  1992-06       Impact factor: 5.662

4.  The genomes of simian varicella virus and varicella zoster virus are colinear.

Authors:  C Y Pumphrey; W L Gray
Journal:  Virus Res       Date:  1992-12       Impact factor: 3.303

5.  Efficacy of (-)-9-[4-hydroxy-2-(hydroxymethyl)butyl]guanine in African green monkeys infected with simian varicella virus.

Authors:  K F Soike; R Bohm; J L Huang; B Oberg
Journal:  Antimicrob Agents Chemother       Date:  1993-06       Impact factor: 5.191

Review 6.  Varicella-zoster virus reactivation without rash.

Authors:  D H Gilden; A N Dueland; M E Devlin; R Mahalingam; R Cohrs
Journal:  J Infect Dis       Date:  1992-08       Impact factor: 5.226

7.  Prevalence and distribution of latent simian varicella virus DNA in monkey ganglia.

Authors:  R Mahalingam; P Clarke; M Wellish; A N Dueland; K F Soike; D H Gilden; R Cohrs
Journal:  Virology       Date:  1992-05       Impact factor: 3.616

8.  Oral bioavailability and anti-simian varicella virus efficacy of 1-beta-D-arabinofuranosyl-E-5-(2-bromovinyl)uracil (BV-araU) in monkeys.

Authors:  K Soike; J L Huang; J I Tu; B Stouffer; J G Mitroka; M Swerdel; S Olsen; D P Bonner; A V Tuomari; A K Field
Journal:  J Infect Dis       Date:  1992-04       Impact factor: 5.226

9.  Simian varicella virus: characterization of virion and infected cell polypeptides and the antigenic cross-reactivity with varicella-zoster virus.

Authors:  T M Fletcher; W L Gray
Journal:  J Gen Virol       Date:  1992-05       Impact factor: 3.891

10.  The simian varicella virus and varicella zoster virus genomes are similar in size and structure.

Authors:  W L Gray; C Y Pumphrey; W T Ruyechan; T M Fletcher
Journal:  Virology       Date:  1992-02       Impact factor: 3.616

View more
  17 in total

1.  Simian varicella virus in pigtailed macaques (Macaca nemestrina): clinical, pathologic, and virologic features.

Authors:  Renee Rosemary Hukkanen; Maggie Gillen; Richard Grant; H Denny Liggitt; Hans-Peter Kiem; Stephen T Kelley
Journal:  Comp Med       Date:  2009-10       Impact factor: 0.982

2.  Cloning the simian varicella virus genome in E. coli as an infectious bacterial artificial chromosome.

Authors:  Wayne L Gray; Fuchun Zhou; Juliane Noffke; B Karsten Tischer
Journal:  Arch Virol       Date:  2011-04-13       Impact factor: 2.574

3.  Generation of a specific-pathogen-free baboon colony.

Authors:  Roman F Wolf; Richard Eberle; Gary L White
Journal:  J Am Assoc Lab Anim Sci       Date:  2010-11       Impact factor: 1.232

Review 4.  Simian varicella virus: molecular virology.

Authors:  Wayne L Gray
Journal:  Curr Top Microbiol Immunol       Date:  2010       Impact factor: 4.291

5.  Recombinant varicella vaccines induce neutralizing antibodies and cellular immune responses to SIV and reduce viral loads in immunized rhesus macaques.

Authors:  V Traina-Dorge; B Pahar; P Marx; P Kissinger; D Montefiori; Y Ou; W L Gray
Journal:  Vaccine       Date:  2010-07-21       Impact factor: 3.641

6.  Severe thrombocytopenia in aged rhesus macaques (Macaca mulatta) infected with simian varicella virus.

Authors:  Lisa C Halliday; Jeffrey D Fortman
Journal:  J Am Assoc Lab Anim Sci       Date:  2011-01       Impact factor: 1.232

7.  The simian varicella virus ORF A is expressed in infected cells but is non-essential for replication in cell culture.

Authors:  Wayne L Gray
Journal:  Arch Virol       Date:  2012-06-08       Impact factor: 2.574

8.  Insights into the pathogenesis of varicella viruses.

Authors:  Océane Sorel; Ilhem Messaoudi
Journal:  Curr Clin Microbiol Rep       Date:  2019-07-06

9.  Simian varicella virus inhibits the interferon gamma signalling pathway.

Authors:  Werner J D Ouwendijk; Suzanne van Veen; Ravi Mahalingam; Georges M G M Verjans
Journal:  J Gen Virol       Date:  2017-10       Impact factor: 3.891

10.  The simian varicella virus uracil DNA glycosylase and dUTPase genes are expressed in vivo, but are non-essential for replication in cell culture.

Authors:  Toby M Ward; Marshall V Williams; Vicki Traina-Dorge; Wayne L Gray
Journal:  Virus Res       Date:  2009-02-04       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.